Medical Condition Malignant Neoplasm Of Prostate

Source:

2009 icd-9-cm diagnosis 185 - malignant neoplasm of prostate

Active Ingredients used for Malignant Neoplasm Of Prostate:

Coenzyme Q10, Cranberry, Flaxseed And Flaxseed Oil, Saw Palmetto, Selenium, Soy, Vitamin C, Vitamin D

Active Ingredient	Uses based on scientific evidence	Grade*
coenzyme q10	one study using a combination that included coq10 did not find a significant effect on psa levels in patients with prostate cancer. although psa levels may be an indicator of cancer, it is unclear whether coq10 would have any effect on cancer treatment of prevention. more study is needed.	c
cranberry (vaccinium macrocarpon)	there is preliminary evidence that cranberry is not effective in preventing urinary symptoms related to pelvic radiation therapy in patients with prostate cancer.	c
flaxseed and flaxseed oil (linum usitatissimum)	there is limited high quality research of the effects of flaxseed or alpha-linolenic acid (which is in flaxseed) on the risk of developing prostate cancer. this area remains controversial as there is some data reporting possible increased risk of prostate cancer with alpha linolenic acid. prostate cancer should be treated by a medical oncologist.	d
saw palmetto (serenoa repens [bartram small)]	there is not enough scientific evidence to recommend the product pc-spes (which contains saw palmetto) for prostate cancer. pc-spes also contains seven other herbs ( chrysanthemum morifolium, isatis indigotica, glycyrrhiza glabra, ganoderma lucidum, panax pseudo-ginseng, rabdosia rubescens, and scutellaria baicalensis ). it has been a popular treatment for prostate cancer, but the u.s. food and drug administration (fda) has issued a warning not to use pc-spes because	c
selenium (se)	initial evidence has suggested that selenium supplementation reduces the risk of developing prostate cancer in men with normal baseline psa (prostate specific antigen) levels and low selenium blood levels. this is the subject of large well-designed studies, including the nutritional prevention of cancer trial (npc) and the ongoing selenium and vitamin e cancer prevention trial (select), as well as prior population and case-control studies. the npc was conducted in 1,312 americans and reported	b
soy (glycine max [l. merr.)]	early research has tested the effects of dietary soy intake on prostate cancer development in humans, but the results have not been conclusive. better research is needed before a recommendation can be made.	c
vitamin c (ascorbic acid)	vitamin c has been used in prostate cancer but there is currently a lack of evidence to determine its effect in this disease.	c
vitamin d	there is preliminary evidence based on laboratory and human studies that high-dose vitamin d may be beneficial in the treatment of prostate cancer. this area is under active investigation, but clear evidence of benefit is not yet available.	d

*Key to grades
A: Strong scientific evidence for this use;
B: Good scientific evidence for this use;
C: Unclear scientific evidence for this use;
D: Fair scientific evidence against this use;
F: Strong scientific evidence against this use.